Stanford Scientists Use AI to Develop Virus Targeting E. coli, Promising New Antibiotic Alternatives
Stanford University researchers have successfully used artificial intelligence to create a virus designed to target and kill E. coli bacteria. This virus, known as a bacteriophage, was developed using a generative AI model called EVO 2. The bacteriophage functions by attacking bacteria, similar to how human viruses attack human cells. This development is part of a broader effort to use bacteriophages as alternatives to traditional antibiotics, which are becoming less effective due to increasing bacterial resistance. The research, published in the journal Science, highlights the potential of AI to design biological functions at a whole-genome scale. The AI-designed bacteriophages are not naturally occurring and have been specifically engineered to combat E. coli. This innovation could significantly reduce the time and cost associated with developing new antibiotics, potentially allowing for the creation of new therapies in just hours instead of years. 
